489 related articles for article (PubMed ID: 28822510)
1. High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis.
Priti K; Agrawal A; Ranwa BL
Indian Heart J; 2017; 69(4):453-457. PubMed ID: 28822510
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
4. Intensive atorvastatin improves endothelial function and decreases ADP-induced platelet aggregation in patients with STEMI undergoing primary PCI: A single-center randomized controlled trial.
Xu X; Liu Y; Li K; Wang P; Xu L; Yang Z; Yang X
Int J Cardiol; 2016 Nov; 222():467-472. PubMed ID: 27505335
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).
Greco C; Pelliccia F; Tanzilli G; Tinti MD; Salenzi P; Cicerchia C; Schiariti M; Franzoni F; Speziale G; Gallo P; Gaudio C
Am J Cardiol; 2013 Sep; 112(5):630-5. PubMed ID: 23711809
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51).
Mega JL; Braunwald E; Murphy SA; Plotnikov AN; Burton P; Kiss RG; Parkhomenko A; Tendera M; Widimsky P; Gibson CM
J Am Coll Cardiol; 2013 May; 61(18):1853-9. PubMed ID: 23500262
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.
Shehata M; Samir A; Dardiri M
J Interv Cardiol; 2017 Dec; 30(6):514-521. PubMed ID: 28812321
[TBL] [Abstract][Full Text] [Related]
9. Association of syntax score with short-term outcomes among acute ST-elevation myocardial infarction patients undergoing primary PCI.
Choudhary S
Indian Heart J; 2017 Apr; 69 Suppl 1(Suppl 1):S20-S23. PubMed ID: 28400034
[TBL] [Abstract][Full Text] [Related]
10. Red cell distribution width is a predictor of ST resolution and clinical outcome following thrombolysis in acute ST elevation myocardial infarction.
Ghaffari S; Pourafkari L; Sepehrvand N; Aslanabadi N; Faridi L; Tajlil A; Masoumi N; Nader ND
Thromb Res; 2016 Apr; 140():1-6. PubMed ID: 26896606
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
[TBL] [Abstract][Full Text] [Related]
12. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
[TBL] [Abstract][Full Text] [Related]
15. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
[TBL] [Abstract][Full Text] [Related]
16. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
[TBL] [Abstract][Full Text] [Related]
17. Effect of statin pretreatment on the outcome of ST-segment elevation myocardial infarction in patients without prior history of coronary artery disease.
Mytas D; Zairis M; Karanasos A; Kosma L; Arsenos P; Tentolouris C; Pitsavos C; Foussas S; Stefanadis C; Cokkinos D
Hellenic J Cardiol; 2013; 54(6):422-8. PubMed ID: 24305577
[TBL] [Abstract][Full Text] [Related]
18. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
[TBL] [Abstract][Full Text] [Related]
19. On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study).
Khera AV; Qamar A; Murphy SA; Cannon CP; Sabatine MS; Rader DJ
Am J Cardiol; 2015 Sep; 116(5):694-8. PubMed ID: 26119654
[TBL] [Abstract][Full Text] [Related]
20. Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010.
Gottlieb S; Kolker S; Shlomo N; Matetzky S; Leitersdorf E; Segev A; Goldenberg I; Tzivoni D; Weisz G; Moriel M
Int J Cardiol; 2016 May; 210():133-8. PubMed ID: 26945433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
